SERPINB3

Revision as of 14:34, 6 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Serpin peptidase inhibitor, clade B (ovalbumin), member 3
Identifiers
Symbols SERPINB3 ; HsT1196; SCC; SCCA-1; SCCA-PD; SCCA1; T4-A
External IDs Template:OMIM5 Template:MGI HomoloGene: 74584
RNA expression pattern
File:PBB GE SERPINB3 209720 s at tn.png
File:PBB GE SERPINB3 209719 x at tn.png
File:PBB GE SERPINB3 210413 x at tn.png
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Serpin peptidase inhibitor, clade B (ovalbumin), member 3, also known as SERPINB3, is a human gene.[1]


See also

References

  1. ↑ "Entrez Gene: SERPINB3 serpin peptidase inhibitor, clade B (ovalbumin), member 3".

Further reading

  • Suminami Y, Kishi F, Sekiguchi K, Kato H (1992). "Squamous cell carcinoma antigen is a new member of the serine protease inhibitors". Biochem. Biophys. Res. Commun. 181 (1): 51–8. PMID 1958219.
  • Mino-Miyagawa N, Kimura Y, Hamamoto K (1990). "Tumor-antigen 4. Its immunohistochemical distribution and tissue and serum concentrations in squamous cell carcinoma of the lung and esophagus". Cancer. 66 (7): 1505–12. PMID 2208001.
  • Mino N, Iio A, Hamamoto K (1988). "Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs". Cancer. 62 (4): 730–4. PMID 2840187.
  • Schneider SS, Schick C, Fish KE; et al. (1995). "A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene". Proc. Natl. Acad. Sci. U.S.A. 92 (8): 3147–51. PMID 7724531.
  • Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. PMID 8125298.
  • Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K; et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. PMID 9373149.
  • Schick C, Pemberton PA, Shi GP; et al. (1998). "Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis". Biochemistry. 37 (15): 5258–66. doi:10.1021/bi972521d. PMID 9548757.
  • Cataltepe S, Gornstein ER, Schick C; et al. (2000). "Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas". J. Histochem. Cytochem. 48 (1): 113–22. PMID 10653592.
  • Uemura Y, Pak SC, Luke C; et al. (2000). "Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells". Int. J. Cancer. 89 (4): 368–77. PMID 10956412.
  • Hamada K, Shinomiya H, Asano Y; et al. (2001). "Molecular cloning of human squamous cell carcinoma antigen 1 gene and characterization of its promoter". Biochim. Biophys. Acta. 1518 (1–2): 124–31. PMID 11267667.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Shimada H, Nabeya Y, Okazumi S; et al. (2003). "Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma". Surgery. 133 (5): 486–94. doi:10.1067/msy.2003.139. PMID 12773976.
  • Micke O, Bruns F, Schäfer U; et al. (2003). "The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neck". Anticancer Res. 23 (2A): 907–11. PMID 12820321.
  • Nawata S, Nakamura K, Hirakawa H; et al. (2004). "Electrophoretic analysis of the cleaved form of serpin, squamous cell carcinoma antigen-1 in normal and malignant squamous epithelial tissues". Electrophoresis. 24 (14): 2277–82. doi:10.1002/elps.200305501. PMID 12874860.
  • Masumoto K, Sakata Y, Arima K; et al. (2003). "Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1". J. Biol. Chem. 278 (46): 45296–304. doi:10.1074/jbc.M307741200. PMID 12949073.
  • Moore PL, Ong S, Harrison TJ (2004). "Squamous cell carcinoma antigen 1-mediated binding of hepatitis B virus to hepatocytes does not involve the hepatic serpin clearance system". J. Biol. Chem. 278 (47): 46709–17. doi:10.1074/jbc.M302842200. PMID 12975381.
  • Onishi A, Nakashiro K, Mihara M; et al. (2004). "Basic and clinical studies on quantitative analysis of lymph node micrometastasis in oral cancer". Oncol. Rep. 11 (1): 33–9. PMID 14654899.
  • Hirakawa H, Nawata S, Sueoka K; et al. (2004). "Regulation of squamous cell carcinoma antigen production by E-cadherin mediated cell-cell adhesion in squamous cell carcinoma cell line". Oncol. Rep. 11 (2): 415–9. PMID 14719077.
  • Pontisso P, Calabrese F, Benvegnù L; et al. (2004). "Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma". Br. J. Cancer. 90 (4): 833–7. doi:10.1038/sj.bjc.6601543. PMID 14970861.
  • Ruvoletto MG, Tono N, Carollo D; et al. (2004). "Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21-47) sequence of hepatitis B virus". J. Gen. Virol. 85 (Pt 3): 621–4. PMID 14993646.

External links

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=SERPINB3&oldid=725256"